BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anthem Biosciences IPO is Open!
Apply for the Anthem Biosciences IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Influx Healthtech Ltd

Pharmaceuticals

Offer Period :

18th to 20th Jun 2025

Influx Healthtech Ltd IPO Details

IPO Date 18th to 20th Jun 2025 Minimum Investment ₹115200 / 2 Lots
Listing Date 2025-06-25 Maximum Investment ₹115200 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹58.57 Crores
Price ₹96 to ₹96 per share Fresh Issue ₹48 Crores
Lot Size 1 Lots (1200 Shares) Offer For Sale ₹ [-]
Listing At NSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 18150000 Shares
Issue Type Book Building - SME Shareholding Post Issue 23150400 Shares
IPO Date 18th to 20th Jun 2025
Listing Date 2025-06-25
Face Value ₹10 per share
Price ₹96 to ₹96 per share
Lot Size 1 Lots (1200 Shares)
Listing At NSE-SME
Total Issue Size ₹58.57 Crores
Employee Discount ₹0 per share
Issue Type Book Building - SME
Minimum Investment ₹115200 / 2 Lots
Maximum Investment ₹115200 / 1 Lots
Fresh Issue ₹48 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 18150000 Shares
Shareholding Post Issue 23150400 Shares

About Influx Healthtech Ltd IPO

Influx Healthtech Limited, incorporated in September 2020, is a healthcare-oriented company that provides contract manufacturing services. Positioned as a Contract Development and Manufacturing Organization (CDMO), it offers end-to-end solutions including product development, manufacturing, and regulatory assistance. The company supports clients across a wide range of industries, particularly in the nutraceutical and cosmetic sectors. Its product portfolio includes tablets, capsules, powders, liquid orals, softgels, jellies, gummies, lozenges, ODFs, effervescent tablets, and more. It also covers personal care products such as skincare, haircare, and hygiene items, along with veterinary feed supplements, homecare solutions, and herbal formulations.
 

Headquartered in Mumbai, the company operates three manufacturing facilities located in Thane, Maharashtra, covering 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft., respectively. These units comply with international quality certifications including GMP, ISO 22000, HACCP, and Halal. As of June 11, 2025, the company has 163 permanent employees on its payroll.

Founding Year: 2020

Managing Director: Munir Abdul Ganee Chandniwala

Influx Healthtech Limited Timeline

Important dates for allocation and IPO listing.

18th Jun

IPO Opens

20th Jun

IPO Close

23rd Jun

Allotment Date

24th Jun

Initiation of Refund

24th Jun

Credit of Shares to Demat Account

25th Jun

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 99.85 73.53
Public Group 0.15 26.47

Influx Healthtech Ltd IPO Reservation

QIB Shares Offered 1159200(19%)
NII (HNI) Shares Offered 870000(14.26%)
Retail Shares Offered 2029200(33.26%)
Anchor Investor Shares Offered 1736400(28.46%)
Total Shares Offered 6100800
Total Shares With Anchor Investor 6100800

Influx Healthtech Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1200 ₹115200
Retail (Max) 1 1200 ₹115200
S HNI (Min) 2 2400 ₹230400
S HNI (Max) 8 9600 ₹921600
B HNI (MIN) 9 10800 ₹1036800

Influx Healthtech Ltd IPO Anchor Investor Details

Bid Date 17 June 2025
Shares Offered 0
Anchor Portion Size 0

Influx Healthtech Ltd IPO Registrar

Maashitla Securities Pvt Ltd
Phone Number +91-11-47581432
Email Id investor.ipo@maashitla.com
Our Website www.maashitla.com

Influx Healthtech Ltd IPO Lead Manager

1. Rarever Financial Advisors Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Influx Healthtech Ltd Financial Information

Period Ended March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹36.15 ₹22.78 ₹11.65
Reserves and Surplus ₹18 ₹22.75 ₹11.63
Total Borrowing ₹0.22 ₹0.32 ₹0.8

Influx Healthtech Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 1159200 159818400 137.8696
Non Institutional Investors (NIIs) 870000 418878000 481.469
NII(Bid amount of more than Ten Lakh Rupees) 0 0 0
NII(Bid amount of more than 2 Lakh < 10 Rupees) 870000 0 0
Retail Individual Investors (RIIs) 2029200 238842000 117.7025
Total 4364400 817538400 187.3198

Strength of Influx Healthtech Ltd

1. Diverse client base with longstanding CDMO relationships.

2. Well versed and equipped advanced manufacturing facilities with global accreditations.

3. Large and rapidly growing R&D capabilities across our product portfolio.

4. Experienced Promoter and management team with strong industry expertise and successful track record.

5. Robust Quality Assurance & Control practices.

6. Proven Track record of growth and profitability.

Risks Involved

1. The Company is reliant on the demand from the nutraceutical industry for a significant portion of its revenue. Any downturn in the nutraceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company's business and results of operations.

2. Its existing manufacturing facility are concentrated in a single region i.e., Palghar, Thane, Maharashtra and the inability to operate and grow its business in this particular region may have an adverse effect on its business, financial condition, results of operations, cash flows and future business prospects.

3. The Company is dependent on few numbers of customers for sales. Loss of any of this large customer may affect its revenues and profitability.

4. The company has historically derived, and may continue to derive, a signification of its supply from top 10 Suppliers. Also, the Company has not entered into long-term agreements with these suppliers. In the event the company is unable to procure adequate amounts of raw materials, at competitive prices its business, results of operations and financial condition may be adversely affected.

5. Too much Geographical concentration of its Business on specific location can impact the company Business.

6. Its reliance on certain industries for a significant portion of its sales could have an adverse effect on its business.

7. The company has not taken any steps to order the machinery/equipment required for the proposed expansion. In the event of any delay in placing the orders, or in the event the vendors are not able to provide the equipment / machineries in a timely manner, or at all, the same may result in time and cost over-runs.

8. Its business activities are exposed to fluctuations in the prices of raw materials.

9. Its may face several risks associated with the construction of the building of the Proposed Expansion, which could hamper its growth, prospects, cash flows and business and financial condition.

10. Its Registered Office, Factory Units and Godown is located on premises which are not owned by it and has been obtained on license basis from the promoters of the company. Disruption of its rights as licensee/ lessee or termination of the agreements with its licensors/ lessors (promoters) may adversely impact its operations and, consequently, its business, financial condition and results of operations.

Why should you invest in

-

Influx Healthtech Ltd Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Influx Healthtech Limited IPO Contact Details

Influx Healthtech Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2025-06-25 93847 INFLUX
INE0MYZ01012
₹96 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹96 ₹96
Open ₹0 ₹132.5
Low ₹0 ₹125.9
High ₹0 ₹135.85
Low ₹0 ₹125.9

Industry Outlook of Influx Healthtech IPO

  • Influx Healthtech functions as a Contract Development and Manufacturing Organization (CDMO), focusing on tailored development and production services.

  • The company works with businesses from diverse sectors, supporting them with end-to-end manufacturing and formulation services.

  • Its role involves custom product development, packaging, and delivery aligned with client specifications.

  • The firm operates across several categories, offering a wide range of product types and SKUs.

  • Its areas of focus include Dietary and Nutritional Supplements, catering to consumer wellness needs.

  • It is active in the Cosmetics sector, addressing skincare and personal care manufacturing requirements.

  • The company also deals in Ayurvedic and Herbal formulations, tapping into traditional and natural product demand.

  • In addition, it manufactures Veterinary Feed Supplements, serving animal health and nutrition segments.

  • The Homecare segment is another operational area, providing products used for domestic cleaning and maintenance.
     

 Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Influx Healthtech IPO.

Frequently Asked Questions

What is Influx Healthtech Ltd IPO?

Answer Field

Influx Healthtech Ltd IPO is a SME IPO of 61,00,800 equity shares of a face value of ₹10 aggregating up to ₹58.57 Crores. The issue is priced at ₹96 to ₹96 per share. The minimum order quantity is 1200 Shares. The IPO opens on June 18, 2025, and closes on June 20, 2025. Maashitla Securities Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Influx Healthtech Ltd IPO will open?

Answer Field

The Influx Healthtech Ltd IPO opens on June 18, 2025 and closes on June 20, 2025.

What is the lot size of Influx Healthtech Ltd?

Answer Field

Influx Healthtech Ltd lot size is 1200 shares, and the minimum amount required is ₹1,15,200.

How to apply for Influx Healthtech Ltd IPO?

Answer Field

You can apply in Influx Healthtech Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Influx Healthtech Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Influx Healthtech Ltd IPO will be done on June 23, 2025, and the allotted shares will be credited to your demat account by June 24, 2025.

When is Influx Healthtech Ltd IPO listing date?

Answer Field

The Influx Healthtech Ltd listing date is June 25, 2025.

Who is the registrar of Influx Healthtech Ltd IPO?

Answer Field

The registrar of Influx Healthtech Ltd IPO is Maashitla Securities Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Rarever Financial Advisors Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Influx Healthtech Ltd IPO?

Answer Field

The fresh issue size is ₹48 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Influx Healthtech Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1200 shares and ₹1,15,200 amount.

How can I approve the UPI mandate request for Influx Healthtech Ltd IPO?

Answer Field

To apply for Influx Healthtech Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Influx Healthtech Ltd?

Answer Field

The price of each Influx Healthtech Ltd share will be ranging in between ₹96 to ₹96 per share.

What is the cut-off time for the UPI mandate for Influx Healthtech Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, June 20, 2025.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • ANTHEM BIOSCIENCES LIMITEDMainboard IPO

  • Bidding Dates

    14th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹540.0 - 570.0

  • IPO Size

    ₹33,95,00,00,000

  • Apply Now
  • SPUNWEB NONWOVEN LIMITEDSME IPO

  • Bidding Dates

    14th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹90.0 - 96.0

  • IPO Size

    ₹60,98,00,000

  • Apply Now
  • MONIKA ALCOBEV LIMITEDSME IPO

  • Bidding Dates

    16th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹271.0 - 286.0

  • IPO Size

    ₹1,53,68,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Bidding Dates

    2nd Jul 2025 - 7th Jul 2025

  • Price Range

    ₹233.0 - 245.0

  • IPO Size

    ₹8,60,00,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Issue Price

    245.00

  • Listing Day Close

    307.45

  • Listing Day (Gain/Loss)

    25.31

  • VANDAN FOODS LIMITEDSME IPO

  • Issue Price

    115.00

  • Listing Day Close

    118.75

  • Listing Day (Gain/Loss)

    3.48

  • NEETU YOSHI LIMITEDSME IPO

  • Issue Price

    75.00

  • Listing Day Close

    110.25

  • Listing Day (Gain/Loss)

    46.67

  • PRO FX TECH LIMITEDSME IPO

  • Issue Price

    87.00

  • Listing Day Close

    99.75

  • Listing Day (Gain/Loss)

    14.94

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.2 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text